Is there an Indian version of Moboxetinib? what is the price

It is understood that there is no Indian version of Mobocertinib/Mobocertinib (Mobocertinib) original drug or generic drug produced and marketed. The original drug of Mobocertinib may be sold in India. At present, the original drug of Mobosetinib is on the market for sale in many countries, and generic drugs of Mobosetinib are also developed and marketed overseas. Common manufacturers include Laos Lucius Pharmaceuticals, Bangladesh Ziska Pharmaceuticals, etc. Their drug ingredients are basically the same as those of the original drugs at home and abroad.

Most EGFR exon 20 insertion driver mutations in non-small cell lung cancer are insensitive to approved EGFR tyrosine kinase inhibitors (TKIs). To address the limitations of existing therapies for EGFR-mutant non-small cell lung cancer, a new irreversible EGFR TKI mobosetinib was specifically designed to effectively inhibit oncogenic variants containing activating EGFR ex20ins mutations with selectivity compared to wild-type EGFR. Compared with approved EGFR TKIs, mobosetinib more effectively inhibited the viability of various EGFRex20ins-driven cell lines and demonstrated in vivo anti-tumor efficacy in patient-derived xenografts and murine orthotopic models.

Mobosetinib The original drug is currently on the market in China and has not yet been included in the medical insurance. SpecificationThe price of 40mg*112 pills per box is about 40,000 yuan, which is very expensive.The Hong Kong version of the original drug Specifications40mg*30 pills per box is priced at more than 7,000 yuan (the price may fluctuate due to exchange rates). The generic drug specification of Moboxetinib produced by Laos pharmaceutical factory is 40mg*120 pills per box. The price may be over more than 4,000 yuan. The price of Moboxertinib produced by Bangladesh pharmaceutical factory is 40mg*60 pills per box. The price may be over 3,000 yuan (the price may fluctuate due to the exchange rate), which is relatively cheap.